(Q35249168)

7 August 2017

title

In vitro activities of tosufloxacin, temafloxacin, and A-56620 against pathogens of diarrhea (English)

1 reference

7 August 2017

0 references

Bryan JP

1

1 reference

7 August 2017

Waters C

2

1 reference

7 August 2017

Sheffield J

3

1 reference

7 August 2017

Krieg RE

4

1 reference

7 August 2017

Perine PL

5

1 reference

7 August 2017

Wagner K

6

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 February 1990

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

34

1 reference

7 August 2017

issue

2

1 reference

7 August 2017

page(s)

368-370

1 reference

Campylobacter enteritis in the United States. A multicenter study

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Erythromycin-resistant Campylobacter infections in Thailand

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Clinical efficacy of ciprofloxacin compared with placebo in bacterial diarrhea

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Ciprofloxacin or trimethoprim-sulfamethoxazole as initial therapy for travelers' diarrhea. A placebo-controlled, randomized trial

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Efficacy of Ciprofloxacin in the Treatment of Chronic Typhoid Carriers

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Use of norfloxacin to treat chronic typhoid carriers

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Antimicrobial therapy for enteric infections and typhoid fever: state of the art.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

Open, prospective study of the clinical efficacy of ciprofloxacin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrhea

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=171591

12 July 2018

Identifiers

DOI

10.1128/AAC.34.2.368

1 reference

7 August 2017

1 reference

7 August 2017

1 reference